Eurobio Scientific SA
Research Eurobio Scientific SA (ALERS) on Bullrun: market cap EUR 215.46M, P/E 45.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALERS
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 215.46M
- P/E45.5
- Financial periodFY2024
- RevenueEUR 154.56M
- Revenue growth18.9%
- Net incomeEUR 4.00M
- Free cash flowEUR 13.45M
- Gross margin46.3%
Valuation Snapshot
latest market cap is EUR 215.46M; P/E is 45.5.
About Eurobio Scientific SA
Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts; AlloMap, for heart transplant follow up; cell culture media, molecular biology reagents, contract manufacturing service, and proprietary antibodies;
Frequently asked questions
What is Eurobio Scientific SA's market cap?
Eurobio Scientific SA's market capitalization is EUR 215.46M.
What is Eurobio Scientific SA's P/E ratio?
Eurobio Scientific SA's price-to-earnings (P/E) ratio is 45.5.
What does Eurobio Scientific SA do?
Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts;